Intrasense (ALINS) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Intrasense (ALINS) has a cash flow conversion efficiency ratio of 2.505x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-2.92 Million ≈ $-3.41 Million USD) by net assets (€-1.17 Million ≈ $-1.36 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Intrasense (ALINS) market capitalisation for the company's overall valuation and market capitalisation.
Intrasense - Cash Flow Conversion Efficiency Trend (2008–2024)
This chart illustrates how Intrasense's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Intrasense Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Intrasense ranked by their cash flow conversion efficiency. See debt repayment capacity of Intrasense to evaluate how effectively operating cash flow covers total debt obligations.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
AVRO INDIA LIMITED
NSE:AVROIND
|
-0.035x |
|
Binasat Communications Bhd
KLSE:0195
|
0.026x |
|
ChoA Pharmaceutical Co.Ltd
KQ:034940
|
-0.016x |
|
OHEIM INT Co.Ltd
KQ:309930
|
0.298x |
|
Narmada Agrobase Limited
NSE:NARMADA
|
0.002x |
|
Advanced Packaging Tech (Malaysia)
KLSE:9148
|
-0.030x |
|
TalkPool AG
ST:TALK
|
0.305x |
|
Buxton Resources Ltd
AU:BUX
|
-0.863x |
Annual Cash Flow Conversion Efficiency for Intrasense (2008–2024)
The table below shows the annual cash flow conversion efficiency of Intrasense from 2008 to 2024. View Intrasense (ALINS) share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €1.65 Million ≈ $1.93 Million |
€-3.73 Million ≈ $-4.36 Million |
-2.256x | -439.26% |
| 2023-12-31 | €7.29 Million ≈ $8.52 Million |
€-3.05 Million ≈ $-3.56 Million |
-0.418x | +57.06% |
| 2022-12-31 | €2.01 Million ≈ $2.35 Million |
€-1.96 Million ≈ $-2.29 Million |
-0.974x | -438.00% |
| 2021-12-31 | €4.99 Million ≈ $5.83 Million |
€-903.00K ≈ $-1.06 Million |
-0.181x | +9.72% |
| 2020-12-31 | €2.15 Million ≈ $2.52 Million |
€-432.00K ≈ $-505.05K |
-0.201x | -121.44% |
| 2019-12-31 | €573.00K ≈ $669.90K |
€536.00K ≈ $626.64K |
0.935x | +166.67% |
| 2018-12-31 | €2.17 Million ≈ $2.54 Million |
€761.69K ≈ $890.50K |
0.351x | -39.39% |
| 2017-12-31 | €1.34 Million ≈ $1.56 Million |
€773.91K ≈ $904.79K |
0.579x | +44.40% |
| 2016-12-31 | €2.26 Million ≈ $2.64 Million |
€905.07K ≈ $1.06 Million |
0.401x | +196.26% |
| 2013-12-31 | €3.59 Million ≈ $4.20 Million |
€-1.50 Million ≈ $-1.75 Million |
-0.416x | -15.27% |
| 2012-12-31 | €5.40 Million ≈ $6.31 Million |
€-1.95 Million ≈ $-2.28 Million |
-0.361x | +85.81% |
| 2011-12-31 | €123.29K ≈ $144.14K |
€-313.74K ≈ $-366.80K |
-2.545x | -10155.88% |
| 2008-12-31 | €4.90 Million ≈ $5.73 Million |
€124.00K ≈ $144.97K |
0.025x | -- |
About Intrasense
Intrasense S.A. designs and develops software solution for advanced visualization and analysis of multimodality medical images under the Myrian name worldwide. It offers the Myriad platform, a visualization solution that provides a suite of clinical tools and artificial intelligence algorithms for prostate, lung, and brain pathologies; and the Liflow solution, an oncological imaging platform that… Read more